إعلان
إعلان
AMPH
Amphastar Pharmaceuticals, Inc.
27.73
USDبرعاية
-0.01
-0.03%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
27.74
+0.01
+0.03%
تقارير أرباح AMPH
النسبة الإيجابية المفاجئة
AMPH تفوق 32 من 40 آخر التقديرات.
80%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$194.29M
/$0.94
التغير الضمني من Q3 25 (Revenue/ EPS)
+1.28%
/+1.08%
التغير الضمني من Q4 24 (Revenue/ EPS)
+4.16%
/+2.17%
Amphastar Pharmaceuticals, Inc. earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, AMPH reported earnings of 0.93 USD per share (EPS) for Q3 25, beating the estimate of 0.84 USD, resulting in a 10.58% surprise. Revenue reached 191.84 مليون, compared to an expected 188.42 مليون, with a 1.81% difference. The market reacted with a -0.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of 0.94 USD, with revenue projected to reach 194.29 مليون USD, implying an زيادة of 1.08% EPS, and زيادة of 1.28% in Revenue from the last quarter.
الأسئلة الشائعة
What were Amphastar Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Amphastar Pharmaceuticals, Inc. reported EPS of $0.93, beating estimates by 10.58%, and revenue of $191.84M, 1.81% above expectations.
How did the market react to Amphastar Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -0.83%, changed from $24.23 before the earnings release to $24.03 the day after.
When is Amphastar Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for Amphastar Pharmaceuticals, Inc.'s next earnings report?
Based on 9
المحللين, Amphastar Pharmaceuticals, Inc. is expected to report EPS of $0.94 and revenue of $194.29M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان